{"disease":{"id":"neurokinin-1-receptor-substance-p-respiratory-illness-inflammation-covid-19-coronavirus","name":"neurokinin 1 receptor substance p respiratory illness inflammation covid 19 coronavirus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04468646","title":"To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Prof. Dr. Fridoon Jawad Ahmad","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}